Merrimack Pharmaceuticals Secures $77,000,000 New Round

  • Feed Type
  • Date
    4/14/2011
  • Company Name
    Merrimack Pharmaceuticals
  • Mailing Address
    One Kendall Square Cambridge, MA 02139
  • Company Description
    Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer.
  • Website
    http://www.merrimackpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $77,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to advance Merrimack’s proprietary pipeline of novel targetedcancer therapeutics.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.